• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性过敏反应的不同表型——来自欧洲过敏登记处的数据。

Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry.

机构信息

Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

Allergy Unit, Department of Dermatology, University Hospital Basel, Basel, Switzerland.

出版信息

Allergy. 2023 Jun;78(6):1615-1627. doi: 10.1111/all.15612. Epub 2022 Dec 20.

DOI:10.1111/all.15612
PMID:36479710
Abstract

BACKGROUND

Drugs are a frequent cause of severe anaphylactic reactions. Here, we analyze a large dataset on drug induced anaphylaxis regarding elicitors, risk factors, symptoms, and treatment.

METHODS

Data from the European Anaphylaxis Registry (2007-2019) with 1815 reported cases of drug-induced anaphylaxis were studied accordingly.

RESULTS

Drugs are the third most frequent cause of anaphylaxis reported in the Anaphylaxis Registry. Among the eliciting groups of drugs analgesics and antibiotics were far most often reported. Female and senior patients were more frequently affected, while the number of children with DIA was low. DIA patients had symptoms affecting the skin and mucous membranes (n = 1525, 84.02%), the respiratory (n = 1300, 71.63%), the cardiovascular (n = 1251, 68.93%) and the gastrointestinal system (n = 549, 30.25%). Drugs caused significant more severe reactions, occurred more often in medical facilities and led to increased hospitalization rates in comparison to food and insect venom induced anaphylaxis. Adrenaline was used more often in patients with DIA than in anaphylaxis due to other causes. Patients with skin symptoms received more antihistamines and corticosteroids in the acute treatment, while gastrointestinal symptoms led to less adrenaline use.

CONCLUSION

The study contributes to a better understanding of DIA, with a large number of cases from Europe supporting previous data, e.g., analgesics and antibiotics being the most frequent culprits for DIA. Female gender and higher age are relevant risk factors and despite clear recommendations, the emergency treatment of DIA is not administered according to the guidelines.

摘要

背景

药物是引发严重过敏反应的常见原因。在此,我们分析了关于药物诱发过敏反应的诱发因素、危险因素、症状和治疗的大型数据集。

方法

对欧洲过敏反应登记处(2007-2019 年)的 1815 例药物诱发过敏反应报告病例进行了研究。

结果

药物是过敏反应登记处报告的第三大常见过敏原因。在诱发药物组中,镇痛药和抗生素报告最多。女性和老年患者更容易受到影响,而儿童 DIA 患者的数量较少。DIA 患者的症状影响皮肤和黏膜(n=1525,84.02%)、呼吸系统(n=1300,71.63%)、心血管系统(n=1251,68.93%)和胃肠道系统(n=549,30.25%)。与食物和昆虫毒液引起的过敏反应相比,药物引起的过敏反应更严重,更常发生在医疗场所,导致住院率增加。与其他原因引起的过敏反应相比,DIA 患者更常使用肾上腺素。在急性治疗中,有皮肤症状的患者接受了更多的抗组胺药和皮质类固醇,而胃肠道症状导致较少使用肾上腺素。

结论

该研究有助于更好地了解 DIA,来自欧洲的大量病例支持了先前的数据,例如,镇痛药和抗生素是 DIA 最常见的罪魁祸首。女性和年龄较大是相关危险因素,尽管有明确的建议,但 DIA 的紧急治疗并未按照指南进行。

相似文献

1
Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry.药物性过敏反应的不同表型——来自欧洲过敏登记处的数据。
Allergy. 2023 Jun;78(6):1615-1627. doi: 10.1111/all.15612. Epub 2022 Dec 20.
2
Drug-Induced Anaphylaxis in Latin American Countries.药物诱导性过敏反应在拉丁美洲国家的发生情况。
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):780-8. doi: 10.1016/j.jaip.2015.05.012. Epub 2015 Jul 2.
3
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry.老年患者的过敏反应——来自欧洲过敏反应登记处的数据。
Front Immunol. 2019 Apr 24;10:750. doi: 10.3389/fimmu.2019.00750. eCollection 2019.
4
Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up.回顾性研究在急诊科或医院治疗的药物性过敏反应:患者特征、处理方法和 1 年随访。
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):46-51. doi: 10.1016/j.jaip.2013.08.012. Epub 2013 Oct 23.
5
Characteristics of drug-induced anaphylaxis in children and adolescents.儿童和青少年药物性过敏反应的特征
Allergy Asthma Proc. 2017 Sep 1;38(5):56-63. doi: 10.2500/aap.2017.38.4064.
6
Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry.毒液诱导过敏反应的表型和危险因素:欧洲过敏登记处的病例对照研究。
J Allergy Clin Immunol. 2021 Feb;147(2):653-662.e9. doi: 10.1016/j.jaci.2020.06.008. Epub 2020 Jun 22.
7
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry.儿童和青少年过敏反应:欧洲过敏反应登记处。
J Allergy Clin Immunol. 2016 Apr;137(4):1128-1137.e1. doi: 10.1016/j.jaci.2015.11.015. Epub 2016 Jan 21.
8
Anaphylaxis: A Decade of a Nationwide Allergy Society Registry.过敏反应:全国过敏学会注册系统的十年回顾。
J Investig Allergol Clin Immunol. 2021 Feb 21;32(1):23-32. doi: 10.18176/jiaci.0515. Epub 2021 Jul 30.
9
Anaphylaxis in an emergency care setting: a one year prospective study in children and adults.急诊环境中的过敏反应:儿童和成人的一年前瞻性研究。
Scand J Trauma Resusc Emerg Med. 2017 Nov 22;25(1):111. doi: 10.1186/s13049-017-0402-0.
10
First European data from the network of severe allergic reactions (NORA).来自严重过敏反应网络(NORA)的首批欧洲数据。
Allergy. 2014 Oct;69(10):1397-404. doi: 10.1111/all.12475. Epub 2014 Aug 16.

引用本文的文献

1
Safety evaluation of deucravacitinib: a real-world analysis based on the FDA adverse event reporting system database.德卡伐替尼的安全性评估:基于美国食品药品监督管理局不良事件报告系统数据库的真实世界分析
Int J Clin Pharm. 2025 Aug 9. doi: 10.1007/s11096-025-01980-6.
2
Recent Insights into the Epidemiology and Management of Anaphylaxis.过敏性反应流行病学与管理的最新见解
Balkan Med J. 2025 Sep 1;42(5):393-404. doi: 10.4274/balkanmedj.galenos.2025.2025-5-86. Epub 2025 Jul 28.
3
Severe drug-associated anaphylaxis: a complementary descriptive analyses of registry cases and spontaneous reports.
严重药物相关性过敏反应:登记病例与自发报告的补充描述性分析
Eur J Clin Pharmacol. 2025 Jun 27. doi: 10.1007/s00228-025-03868-w.
4
Recent findings from the anaphylaxis registry: Where are we, where do we want to go?过敏反应登记处的最新发现:我们现在何处,又想去何方?
Allergol Select. 2025 Mar 6;9:21-27. doi: 10.5414/ALX02529E. eCollection 2025.
5
Recommendations on how to proceed in case of suspected allergy to penicillin/β-lactam antibiotics: Position paper of the German Society for Allergology and Clinical Immunology (DGAKI) in cooperation with the German Society for Pediatric Allergology (GPA), Austrian Society for Allergology and Immunology (ÖGAI) and the Swiss Society for Allergology and Immunology (SGAI).关于疑似对青霉素/β-内酰胺类抗生素过敏时如何处理的建议:德国变态反应学与临床免疫学会(DGAKI)与德国儿童变态反应学会(GPA)、奥地利变态反应学与免疫学学会(ÖGAI)以及瑞士变态反应学与免疫学学会(SGAI)合作发布的立场文件。
Allergol Select. 2025 Mar 6;9:28-39. doi: 10.5414/ALX02531E. eCollection 2025.
6
Risk Factors for Refractory Anaphylaxis in the Emergency Department.急诊科难治性过敏反应的危险因素
Emerg Med Int. 2024 Nov 11;2024:9640278. doi: 10.1155/2024/9640278. eCollection 2024.
7
The Role of the Basophil Activation Test in the Diagnosis of Drug-Induced Anaphylaxis.嗜碱性粒细胞活化试验在药物性过敏反应诊断中的作用
Diagnostics (Basel). 2024 Sep 13;14(18):2036. doi: 10.3390/diagnostics14182036.
8
Anaphylaxis in a country where Asia and Europe meet: Evaluation according to World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) diagnostic criteria.在一个亚洲与欧洲交汇的国家发生的过敏反应:依据世界过敏组织(WAO)和欧洲变态反应与临床免疫学会(EAACI)诊断标准进行的评估
World Allergy Organ J. 2024 Sep 11;17(9):100962. doi: 10.1016/j.waojou.2024.100962. eCollection 2024 Sep.
9
Risk factors for drug hypersensitivity reactions in children.儿童药物过敏反应的危险因素。
Ital J Pediatr. 2024 Jul 15;50(1):127. doi: 10.1186/s13052-024-01694-x.
10
Drug-Induced Anaphylaxis in Children.儿童药物性过敏反应
Biomedicines. 2024 Feb 27;12(3):527. doi: 10.3390/biomedicines12030527.